Lazard Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
157,000
+22,637
| +17% | +$424K | ﹤0.01% | 886 |
|
|
2025
Q1 | $2.42M | Buy |
134,363
+103,523
| +336% | +$1.86M | ﹤0.01% | 904 |
|
|
2024
Q4 | $518K | Buy |
30,840
+10,828
| +54% | +$182K | ﹤0.01% | 1356 |
|
|
2024
Q3 | $323K | Buy |
+20,012
| New | +$323K | ﹤0.01% | 1503 |
|
|
2024
Q2 | – | Sell |
-328
| Closed | -$4K | – | 2399 |
|
|
2024
Q1 | $4K | Sell |
328
-4,287
| -93% | -$52.3K | ﹤0.01% | 1910 |
|
|
2023
Q4 | $66K | Buy |
+4,615
| New | +$66K | ﹤0.01% | 1813 |
|
|
2023
Q2 | – | Sell |
-3,984
| Closed | -$52K | – | 2511 |
|
|
2023
Q1 | $52K | Buy |
+3,984
| New | +$52K | ﹤0.01% | 1780 |
|
|
2022
Q4 | – | Sell |
-4,141
| Closed | -$48K | – | 2540 |
|
|
2022
Q3 | $48K | Buy |
+4,141
| New | +$48K | ﹤0.01% | 1811 |
|
|
2021
Q3 | – | Sell |
-1,709
| Closed | -$74K | – | 2269 |
|
|
2021
Q2 | $74K | Hold |
1,709
| – | – | ﹤0.01% | 1437 |
|
|
2021
Q1 | $58K | Buy |
+1,709
| New | +$58K | ﹤0.01% | 1377 |
|
|
2020
Q3 | – | Sell |
-2,566
| Closed | -$46K | – | 1720 |
|
|
2020
Q2 | $46K | Buy |
+2,566
| New | +$46K | ﹤0.01% | 1250 |
|
|
2020
Q1 | – | Sell |
-735
| Closed | -$15K | – | 1717 |
|
|
2019
Q4 | $15K | Buy |
+735
| New | +$15K | ﹤0.01% | 1309 |
|